The Infectious Disease Alliance (ID Alliance) will host a hybrid event titled “Bridging Science, Advocacy, and Practice: A Unified Approach to Combating Antimicrobial Resistance,” taking place in Statens Serum Institut (SSI) Campus, Copenhagen, Denmark, and online via Teams. This event will bring together global experts, policymakers, researchers, and advocates to explore collaborative approaches for addressing antimicrobial resistance (AMR) as a growing global challenge that cuts across human health, animal health, agriculture, and the environment.
Search
MEMBERS
- 19Labs
- AbbVie
- Accenture
- Africa Health Business
- AIfluence
- Airbnb
- Americares
- Ananya Health
- Antara International
- Baraka Impact Finance
- Boston Consulting Group
- CCBRT
- Cepheid
- Chevron
- Clinton Global Initiative
- Connective Impact
- Consortium of Universities for Global Health
- Cross-Border Impact Ventures
- Ending Pandemics
- ETR
- Fistula Foundation
- Friends of Chidamoyo
- Friends of the Global Fight
- GAIA Global Health
- Gilead Sciences
- Global Environment & Technology Foundation
- Global Fund for Women
- Global Health Corps
- Global Health Council
- Global Health Technologies Coalition
- Global Impact Advisors
- Global Strategies
- HealthAI
- Hesperian Health Guides
- HOPO Therapeutics
- Ideo.org
- Ipas
- John Snow, Inc.
- Kainomyx
- Kapnek Trust USA
- Kupona Foundation
- L.E.K. Consulting
- LivingGoods
- Mastercard
- Maya Health Alliance
- Medicines360
- MedShare
- Merck
- Meta
- Nivi
- North Carolina Global Health Alliance
- OmniVis
- OPHID
- PATH
- Pathfinder International
- Pendulum
- Pfizer
- Planetary Health Alliance
- Population Services International
- Public Health Institute
- Resonance
- ReSurge International
- Roche Diagnostics
- Sabin Vaccine Institute
- San Francisco Community Health Center
- Seed Global Health
- Simprints
- Stanford University
- — Stanford University Byers Center for Biodesign
- — Stanford University Center for Innovation in Global Health
- — Stanford University School of Medicine
- Street Business School
- Tiba Foundation
- UK Science & Innovation Network
- UNICEF
- University of California
- — UC Berkeley
- — UC Berkeley Center for Emerging and Neglected Diseases
- — UC Berkeley Haas School of Business
- — UC Berkeley School of Public Health
- — UC Davis
- — UC Davis Institute for Pandemic Intelligence
- — UC Global Health Institute
- — UCSF
- — UCSF Institute for Global Health Sciences
- UpSwell
- Viamo
- Vir Biotechnology
- Washington Global Health Alliance
- Watsi
- World Health Organization
- World Telehealth Initiative
- YLabs
- Zenysis
TOPICS
REGIONS
- Africa
- — Cameroon
- — Côte d’Ivoire
- — Ethiopia
- — Guinea
- — Kenya
- — Malawi
- — Mozambique
- — Niger
- — Rwanda
- —— Kigali
- Asia
- — Nepal
- — Pakistan
- — Bangladesh
- — Indonesia
- —— Bali
- — Israel
- Europe
- — Switzerland
- —— Geneva
- South America
- — Brazil
- North America
- — California
- —— Berkeley
- —— Los Angeles
- —— Sacramento
- —— San Francisco
- —— Stanford
- — New York
- —— New York City
- — North Carolina
- —— Durham
- — Washington
- —— Seattle
- — Washington D.C.
Outcomes-Based Finance as a Tool for Health Equity and Innovation
Join Stanford Mussallem Center for Biodesign on February 25 for the next session in their Innovation and Health Equity Discussion Series where Neha Agarwal, senior director of strategy at PATH and Alliance board vice chair, will discuss an innovative outcomes-based financing (OBF) mechanism being developed in partnership with the governments of Tanzania and Senegal, the Bay Area Global Health Alliance, and Pfizer to reinforce antimicrobial stewardship efforts in LMICs.
PATH, Pfizer, and the Bay Area Global Health Alliance Partner to Combat Antimicrobial Resistance in Senegal and Tanzania Using an Outcomes-Based Financing Mechanism
During the Clinton Global Initiative (CGI) 2024 Annual Meeting, PATH, in partnership with the Bay Area Global Health Alliance and Pfizer, announced a Commitment to Action: Outcomes-Based Financing as a Tool to Curb AMR in LMICs. This commitment aims to combat antimicrobial resistance (AMR) and incentivize antimicrobial stewardship (AMS) through an innovative outcomes-based financing mechanism.
AMR takes center stage at UN assembly
GHTC Read More
Essentials for epidemic preparedness and response
PATH Read More
UNGA 79 and Climate Week | Acting Together to Shape the Development of Our Future, Alliance Members Gather in NYC
In September 2024, the United Nations General Assembly will convene in New York to confront complex global challenges during its 79th session (UNGA 79). Included in the high-level agenda is the Summit of the Future, as well as High-Level Meetings on antimicrobial resistance (AMR) and the existential threats posed by sea-level rise. In parallel, Climate Week will bring together over 600 events and activities across NYC, with Nature, Food Systems and Health as a key theme. The Bay Area Global Health Alliance and many of its members will be in NYC to take part in the action that is shaping the development of our future.
Call to action: Advancing global cooperation, R&D, and equity to address AMR
GHTC Read More
UNGA79
The 79th session of the UN General Assembly (UNGA 79) will open on Tuesday, 10 September 2024. The first day of the high-level General Debate will be Tuesday, 24 September 2024. When global leaders meet at the UN, they will confront yet another year of complex crises and conflicts — as a deeply divided world watches. The UN is the only place on Earth where countries — whether big or small — have a say. The debates and conversations that will unfold during UNGA 79 will shape the solutions that can redefine our future. UNGA 79 will also include High-level Meetings on two issues of existential importance: Antimicrobial resistance (AMR) and the global threat of sea-level rise.
The Trinity Challenge on Antimicrobial Resistance – eight finalists selected for up to £1 million prize
Living Goods, Pendulum Read More
GHTC provides recommendations for World Health Assembly at HHS stakeholder listening session
GHTC Read More
UC Davis: Rx One Health Field Institute
Novel pathogens, climate change, biodiversity loss, food insecurity, health disparities, antimicrobial resistance, water scarcity, pollution… our planet faces a host of interrelated serious challenges in the Anthropocene era. The Rx One Health Field Institute at Alliance member UC Davis is a transformative field-based experiential learning course focused on One Health core competencies for graduate students and early career professionals from all disciplines.
The Race Against Resistance: Global Perspectives on Tackling AMR
Join Cepheid for their Race Against Resistance: Global Perspectives on Tackling AMR webinar, which will share cross-regional expertise, including real-world lived experience of managing outbreaks, meta-analysis and novel diagnostic approaches in the fight against antimicrobial resistance and threat to last-line antibiotics.
The State of the Alliance 2023
As 2023 comes to a close, we reflect on what the Bay Area Global Health Alliance has accomplished, how we have shifted to meet the moments and our members’ needs, and where we need to go to advance global health equity and innovation.